What one share of Anbio Biotechnology holds
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions.
Anbio Biotechnology’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Sales | $0.20 |
|---|---|
| Profit | $0.15 |
| Cash and investments | $0.18 |
| Book value | $0.69 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | $0.31 | $0.11 | — | — | — | $0.69 |
| 2024 | $0.19 | $0.06 | — | — | — | $0.41 |
| 2025 | $0.20 | $0.15 | — | — | — | $0.69 |
Common questions about Anbio Biotechnology
How much does one share of Anbio Biotechnology earn?
Over its latest fiscal year, each share of Anbio Biotechnology earned $0.15 of profit on $0.20 of sales, keeping about 74¢ of every $1 (profit margin).
Does Anbio Biotechnology pay a dividend?
Anbio Biotechnology didn’t pay a dividend over its latest fiscal year, according to its SEC filings.
What is Anbio Biotechnology’s book value per share?
Anbio Biotechnology’s book value is $0.69 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of December 31, 2025.
How much cash and debt does each share of Anbio Biotechnology have?
Each share of Anbio Biotechnology has $0.18 of cash and investments, as of December 31, 2025.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.